AllQuantitative Report
Argus•September 11, 2024
Argus•September 11, 2024OGN: What does Argus have to say about OGN?
Summary
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company'
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- KD: What does Argus have to say about KD?Sep 18, 2024 •
KD
- WAB: Raising target price to $183.00Sep 18, 2024 •
WAB
- CI: Lowering target price to $392.00Sep 18, 2024 •
CI
- LW: Raising target price to $53.00Sep 18, 2024 •
LW
- CTLT: What does Argus have to say about CTLT?Sep 18, 2024 •
CTLT